chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), NECK PAIN (Neck was a little sore), BACK PAIN (Back hurting), TEMPERATURE REGULATION DISORDER (Trouble getting warm) and ARTHRALGIA (Joint pain) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Type 1 diabetes mellitus since an unknown date and COVID-19 in December 2020.    On 14-Jan-2021 at 8:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced NECK PAIN (Neck was a little sore), BACK PAIN (Back hurting), HEADACHE (Hadache) and FATIGUE (Tired). On 14-Jan-2021 at 6:00 PM, the patient experienced PAIN (Body aches), TEMPERATURE REGULATION DISORDER (Trouble getting warm), ARTHRALGIA (Joint pain) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN (Body aches), NECK PAIN (Neck was a little sore), BACK PAIN (Back hurting), TEMPERATURE REGULATION DISORDER (Trouble getting warm), ARTHRALGIA (Joint pain), CHILLS (Chills), HEADACHE (Hadache) and FATIGUE (Tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Jan-2021, Blood glucose increased: elevated (High) Blood sugar is elevated.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
The second cycle after the 2nd dose was a 30 day cycle and I spotted for 10 days and currently have a medium flow; The second cycle after the 2nd dose was a 30 day cycle and I spotted for 10 days and currently have a medium flow; Chills; Body aches; Headache; Sweat for 24 hours; This is a spontaneous report from a contactable consumer. A female consumer (patient) reported for herself. A 37-year old non-pregnant female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-119 VACCINE, Solution for injection, Lot number: EN6202), administered in left arm on 14Apr2021 04:45 PM as dose 2, single for COVID-19 immunisation. Age at vaccination was 36-year-old. Patient was not pregnant at the time of vaccination. The patient's medical history and concomitant medications was not reported. The patient's medical history and concomitant medications was not reported. No known allergies. No relevant past drug history. Historical vaccine of BNT162B2 as first dose for Covid-19 immunisation (Time: 04:00 PM, location: Left arm, Batch/Lot number: ER2613) and events occured irregular menstrual cycle, (first cycle after the first dose was a 40 day cycle. My cycle is typically 26-28 days and VERY heavy lasting about 5 days), fatigue, arm soreness and patient underwent labs and procedure included Covid test post vaccination (Nasal swab): negative on 26Mar2021. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. It was reported that, the second cycle of menstruation after the 2nd dose was a 30 day cycle and she spotted for 10 days and had a medium flow at the time of this report. She stated that it was unknown when it will end. She was usually very regular. After getting the vaccine, she had no idea when her period was coming. After the 2nd vaccine she also experienced chills, body aches, headache and sweat for 24 hours. Outcome of events was unknown.  Additional information has been requested.
Patient has redness, swelling, and warmth to area of arm where vaccination was given. She went to the doctor and they gave her antibiotics in case of cellulitis.
I received a flu vaccine in the upper left arm on 11/06/2018. Immediately after receiving the shot it hurt, the pain worsened over the next few days and I took ibuprofen to help with pain. My arm became so painful that I thought I would get a frozen shoulder, I immediately started exercises at home for bursa injury(exercises were home exercises that I found on the internet). Gradually over the course of several months, the pain worsened. I did not have any pain or injury to this arm prior to receiving the vaccine. The injection site was high up on the arm, and in my opinion, the placement was too high possibly hitting a structure in my shoulder that caused some damage of some type. I notified my doctor of this continued pain because it is disrupting my sleep, activities of daily living and function of the left arm. My physician took an X-ray and referred me to physical therapy and blew off my idea that the injury was received as a result of vaccine injury. I asked my physician for an MRI, but have, thus far, been denied. Physician wants me to continue with Physical Therapy and possibly have acupuncture. I have been compliant with all prescribed physical therapy and have noticed an increase in range of motion, but the pain continues. The pain awakens me from sleep at night frequently. The pain causes me to not be able to lift as much with my left arm as my unaffected arm (right). I am reporting this because it has been some time, in my opinion, since this injury and I am not healing fully with my current treatment. I have recently messaged my doctor and she now is saying she thinks it is arthritis. I have arthritis in my knees and frankly this pain is much more severe than any arthritis pain the I have felt and it is not alleviated with any current medications that I have been taking (anti inflammatory medications prescribed and over the counter). My doctor recently has prescribed diclofenac and I am awaiting the arrival of this medication. I am hoping that this injury is not permanent, but have decided to report so that there is a record of my injury even though my physician is not admitting that it is a vaccine injury.
I woke up with the worst migraine ever. All my muscles hurt so bad and started twitching. Went to my primary doctor and he referred me to a Neurologist. At the appointment with the Neurologist, it was confirmed I was having twitches in the muscles but it had nothing to do with neuro.
Swelling of Right arm into Right breast along with neck and ear pain. Redness and extremely hot to the touch. Unable to move arm. Went to Dr. on 11/09/16 and was given Amoxicillin.
Fever, Skin Rash, Urticaria Pruritus & weakness. Diphenhydramine 25 mg PRN.
Information was received from a registered nurse referring to multiple unspecified patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant therapies were not provided. On unspecified dates, multiple unspecified patients were vaccinated with improperly stored VARIVAX (lot# M008171 with expiration date 16-FEB-2018; concentration, route and frequency were unknown) for prophylaxis. No adverse effects were reported. The vaccines were stored at more than minus 15 Celsius degree (C) but less than minus 10 C for 1 hour 38 minutes. The data logger was involved. There was no previous temperature excursion. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1703USA005921: US-009507513-1703USA005922.
This case was reported by a physician and described the occurrence of facial hives in a 2 month old female patient who received hep-B vaccine.    On 09 JUN 2004, the patient received a dose of Energix-B.  At an unspecified period of time following the vaccination the patient experienced "a few hives" on the face.  The event resolved on an unspecified date.
I got a rash behind my ears.  I have had these ever since Jan of 2021.  I went to the doctor about this.  They did not do any test and they gave me a cream for it.
Patient had been losing muscle mass and weight and had trouble controlling his bladder. A visit to his pediatrician found his blood sugar to be over 800mg. He was immediately hospitalized.
The pt is a 12 yo boy who became progressively disoriented and atoxic started two days prior to admitting to hospital. One week prior he came down with atypical chickenpox. He received his chicken pox vaccination on 10/12/1995. Discharge diagnosis: post infections cerebella atoxia.
pt recvd booster dose of Engerix-B 15JAN92 or 17JAN92 w/in hrs had flu-like sx, sore throat, heart murmur; had several visits to MD;
One week (almost exactly) after getting the first vaccine, I had what looked like a spider bite - raised itchy hive, with a red circle around it. Itchy, kind of hard, but no other pain or issues. The hive went away but the red circle stayed for about 4-5 days (getting darker and lighter. Allergy meds helped).  Additionally, a day after getting the first vaccine (about 24 hours after), I was lethargic and extremely low energy with a temp of 100. This lasted maybe three hours and then I was fine.
Violent nausea and Vomiting, Severe Migraine that only lasted 6 hours, and Hindered vision.
Pericarditis; Bradycardia; This is a spontaneous report from a contactable consumer. This contactable 33-year-old male consumer (patient) received bnt162b2 (BNT162B2, Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number EW0187), via an unspecified route of administration, administered in Arm Left on 13Jul2021 10:30 as dose umber unknown, single for COVID-19 immunisation (Age at Vaccination 33 years). Medical history included cardiac failure, epilepsy, hypothyroidism, coronary artery disease, gastroesophageal reflux disease, drug hypersensitivity (Penicillin). The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, patient been tested for COVID-19 it was unknown. On 16Jul2021 07:00 patient experienced pericarditis, bradycardia, heart rate under 60bpm 47bpm, swelling of heart. The patient underwent lab tests which included heart rate: under 60bpm 47bpm on 16Jul2021. The events did not result into death/ Life threatening/ Caused/prolonged hospitalization/ Disabling/Incapacitating/Congenital anomaly/birth defect. The adverse event result in Emergency room/department or urgent care. No treatment was received as result of events. The outcome of all events was not recovered.
pregnant during vaccination two; pregnant during vaccination one; This spontaneous pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (pregnant during vaccination one) and EXPOSURE DURING PREGNANCY (pregnant during vaccination two) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 092A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 06-Aug-2021. On 26-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (pregnant during vaccination one). On 25-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (pregnant during vaccination two). At the time of the report, EXPOSURE DURING PREGNANCY (pregnant during vaccination one) and EXPOSURE DURING PREGNANCY (pregnant during vaccination two) outcome was unknown.            No relevant Concomitant medications were provided. No Treatment Information provided.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this 27-year-old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy
This spontaneous report was received from a healthcare worker refers to multiple unspecified patients of unknown gender and age. Information regarding patients' medical history, concurrent conditions, drug reactions/allergies and concomitant therapy were not provided. On unknown dates, the patients were vaccinated with improperly stored doses of PNEUMOVAX 23 (thepay type: Digital data logger; lot # K018183, expiry date: 04-MAY-2016; lot # L024132, expiry date: 21-JAN-2017. Healthcare worker stated that the vaccine underwent a temperature excursion at 49.5 degree Fahrenheit for 186 hours. There were no previous temperature excursions. Healthcare worker confirmed that the vaccine was administered on unspecified dates before their expiration date. No adverse effects were reported. This is one of the six reports received from the same reporter. Additional information has been requested.
Patient received Flu vaccine about 90 minutes later patient started to feel tingling in her tounge, her lips went completely numb, and her throat felt very tight.  Patient was given 25mg of PO Benadryl and after 20 minutes, throat felt better, tounge stopped tingling but lips still numb and a bit swollen. Patient had no other new meds.
Pt describes becoming warm, tingling around ears, tightness in thoroat.  Pt was moved to a room to be more closely monitored.  Symptoms resolved without medications being given.
pt recv vax 5AUG96 w/PE done in usual fashion;mom stated soreness in that arm, then pain in armpit; to MD & swollen gland in armpit noted-? immun technique & put on ATB;pt ill;pt hosp w/high fever, WBC high;allerg to ATB & rxn to vax;
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 31-OCT-2007, the patient was inoculated with the ZOSTAVAX vaccine as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot number not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. On or about 19-OCT-2016, the patient was treated for a blistering vesicular outbreak that was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown.  Causality assessment was related. Additional information has been requested.
Given Pfizer #1 instead of Moderna #2.  No side effects or adverse outcomes noted.
Nausea; Jumpiness; body aches; Chills; arm hurting; Fever; This is a spontaneous report from a contactable consumer. A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number EK9231/expiration date Apr2021), dose number 1, via an unspecified route of administration on 04Jan2021 14:30 at a single dose on the left arm for COVID-19 immunisation. The patient had no relevant medical history. The patient previously had a flu shot for immunization and experienced fever, body aches, jumpiness, and arm hurting. She had no concomitant medications. She did not have any vaccination within 4 weeks prior the administration of the suspect vaccine. The patient was reporting side effects with the Pfizer vaccine. The events started in the morning of 05Jan2021 with the feeling of nausea. She also experienced jumpiness. In the evening, she had body aches, chills, and arm hurting. She also had fever, but it was not a very high fever. She took Tylenol on 05Jan2021 and on 06Jan2021, she had no body aches or fever yet. She felt much better on 06Jan2021. Her second dose is scheduled on the 25Jan2021. The patient received the vaccine at a workplace clinic. The outcome of the event was recovering.
This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 28-DEC-2016, the patient was vaccinated with an improperly stored dose of PROQUAD lot number M035690, expiration date 06-FEB-2018 (dose and route of administration were not reported) for prophylaxis. There was no adverse effect reported. Administered dose of vaccine was exposed to a temperature excursion of "12 degrees F >5 degrees F but <14 degrees F" for 2 hours. Data logger was involved. There were no previous excursions reported. This is one of two reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1701USA007293.
subsequent to receiving varicella virus vaccine live the pt developed a rash, itching on lower extremities and unknown number of skin lesions. The pt was noted to be afebrile. Follow up information indicated that the pt developed what was clinically chickenpox.
Tested positive for Covid-19 on 8/23/2021.  Admitted for AMS on 8/27/2021
doses administered past the published expiry; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the published expiry) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the published expiry). On 16-Sep-2021, EXPIRED PRODUCT ADMINISTERED (doses administered past the published expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications are provided by the reporter.  The vials were stored in the freezer and taken out of the freezer and placed in the refrigerator on the date of administration. The vials did not undergo any temperature excursions.
Patient came back and said she had pain in the left arm where she got the shot. She said Flexeril  & Tramadol help with the pain. She's being treated by MD for this pain.
Started 4 days post vaccine  (1/11/21) and lasted 10 -12 days. Tightness in chest and neck. Fullness in chest that radiated up to neck w/ warm feeling.  Feeling of faintness. Headache. Rapid heart rate while sitting or standing., bending over. Left eye blind spot; 20 minutes on 1/16/21. Anxiety. Advil, Dayquil did not change any of the symptoms. Some residual anxiety issues regarding tightness and rapid heart rate.
patient claims double vision beginning 02/14/20, and imbalance 02/15/20, claims has seen multiple physicians including a neurologist.
face redness; Headache so bad thought my head was going to explode; fever; muscle aches; chills; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female patient (non-pregnant) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in arm left on 06Mar2021 10:15 (at the age of 50-year-old), at a 2nd dose, single dose for covid-19 immunisation. Medical history included Hbp (Hypertension), hashimoto disease, asthma, patient was allergic Sulfa, penicillin, patient had covid prior vaccination. Concomitant medications included montelukast sodium (SINGULAIR); levothyroxine; propranolol; vitamins nos (MULTIVITAMINS). Historical vaccine included first dose BNT162B2 for covid-19 immunisation. On an unspecified date in Mar2021 the patient experienced Headache so bad thought her head was going to explode, fever, muscle aches, chills, face redness. Patient did not receive treatment for the adverse event. Patient did not tested covid post vaccination. Outcome of the events was resolved on an unspecified date in 2021.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
23DEC dx w/chickenpox red macular papular rash (approx 20 lesions) most on trunk;some papules progressed to vesicles;febrile, sl achy;tx veltrex;seen 5JAN97 no rash or evidence of varicella;
Significantly stronger cramping during my next menstrual cycle. Also more heavy bleeding during menstrual cycle.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Shakiness-Mild, Additional Details: patient appeared to have a panic attack which almost turned into a fainting spell right after vaccination was given. EMS was called, all her vitals were normal and she recovered. did not go to the hospital. no signs of allergy to the vaccine.
Swelling of the lymph node of my left clavicle and the lymph node in my left axillary area. The swelling of the lymph nodes resolved in about 1 week.  I had what felt like a build up of fluid around my heart and inflammation of my heart, which I believe to have been pericarditis and myocarditis.  The heart inflammation resolved in approximately 2 weeks.  Flu like symptoms for a 8 hour period about 24 hours after my second vaccination.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 39-year-old male patient received BNT162b2 (BNT162B2), on 08Nov2021 as dose 3 (booster), single (Lot number: FG3524) at the age of 38 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "No" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Paxlovid treatment start date=30Aug2022, stop date=04Sep2022. No known allergies.
HPV was administered first on left arm. MENVEO was administered next, pt complained of burning in the arm. Nurse advised to move arm. After moving arm, pt had dizziness, then fainting spell for less than 1 min. Doctor gave juice and monitored patient's BP and heart rate for the next 30 mins. Patient resumed normal mented status and exam in 5 minutes. BP went up with fluids and did not complain of any dizziness.
Information has been received on 15-FEB-2019 regarding a case in litigation from a lawyer and a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the ZOSTAVAX vaccine by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On or about 03-MAR-2016, the patient was administered the ZOSTAVAX by a healthcare provider at a family medicine office (lot number, dosage and route of administration not provided). On an unknown date, the patient was treated by a healthcare provider at a family medicine office for the following injury resulting from the ZOSTAVAX use: Shingles. The patient claims damages including: injury to herself and economic losses. The outcome of the shingles was unknown. Causality related. Additional information has been requested.